Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study

Table 6 Antimicrobial susceptibility (percentage) of Enterobacteriaceae isolates causing bloodstream infection

Antimicrobial	Klebsiella		Salmonella		E. coli		Other*		Total
	CA 19	HA 34	CA 27	HA 12	CA 24	HA 13	CA 9	HA 6	CA 79	HA 65
Ampicillin	0	0	52	33	4	15	11	33	20	12
Amoxicillin-clavulanate	53	62	70	67	75	31†	11	17	61	52
Cefuroxime	74	85	93	100	88	54†	56	50	82	78
Ceftazidime	79	85	96	100	88	46†	56	50	85	77
Cefotaxime	78	85	96	100	88	50†	56	67	84	80
Meropenem	100	100	100	100	100	100	100	100	100	100
Gentamicin	53	53	74	67	71	54	33	50	63	55
Doxycycline	58	71	85	75	13	23	33	17	51	57
Co-trimoxazole	37	6†	52	33	13	23	22	50	33	18
Chloramphenicol	47	56	85	67	33	46	22	50	53	55
Ciprofloxacin	100	100	100	100	92	92	89	100	96	98

CA, community-acquired infection; HA, hospital-acquired infection. *Other isolates include Enterobacter spp., (9), Pantoea spp. (2), Serratia marcescens (1), Shigella flexneri (1), Citrobacter freundii (1), Proteus mirabilis (1). † Statistically significant difference in susceptibility among hospital-acquired and community-acquired isolates, p < 0.05 by two-sided Fisher's exact test.